Northern Trust’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-7,491
| Closed | -$25.9K | – | 4447 |
|
|
2024
Q3 | $25.9K | Hold |
7,491
| – | – | ﹤0.01% | 4311 |
|
|
2024
Q2 | $38K | Buy |
7,491
+3,838
| +105% | +$28.8K | ﹤0.01% | 4247 |
|
|
2024
Q1 | $30.9K | Hold |
3,653
| – | – | ﹤0.01% | 4292 |
|
|
2023
Q4 | $15K | Hold |
3,653
| – | – | ﹤0.01% | 4390 |
|
|
2023
Q3 | $11K | Hold |
3,653
| – | – | ﹤0.01% | 4396 |
|
|
2023
Q2 | $113K | Sell |
3,653
-75
| -2% | -$3.11K | ﹤0.01% | 4005 |
|
|
2023
Q1 | $185K | Hold |
3,728
| – | – | ﹤0.01% | 3893 |
|
|
2022
Q4 | $91.7K | Hold |
3,728
| – | – | ﹤0.01% | 4115 |
|
|
2022
Q3 | $247K | Hold |
3,728
| – | – | ﹤0.01% | 3774 |
|
|
2022
Q2 | $154K | Hold |
3,728
| – | – | ﹤0.01% | 4017 |
|
|
2022
Q1 | $188K | Sell |
3,728
-211
| -5% | -$10.4K | ﹤0.01% | 4158 |
|
|
2021
Q4 | $236K | Hold |
3,939
| – | – | ﹤0.01% | 4139 |
|
|
2021
Q3 | $195K | Buy |
3,939
+622
| +19% | +$32.7K | ﹤0.01% | 4195 |
|
|
2021
Q2 | $189K | Sell |
3,317
-16,645
| -83% | -$889K | ﹤0.01% | 4179 |
|
|
2021
Q1 | $1.15M | Sell |
19,962
-344
| -2% | -$26K | ﹤0.01% | 3525 |
|
|
2020
Q4 | $1.38M | Sell |
20,306
-862
| -4% | -$117K | ﹤0.01% | 3374 |
|
|
2020
Q3 | $5.37M | Buy |
21,168
+15,880
| +300% | +$3.25M | ﹤0.01% | 2496 |
|
|
2020
Q2 | $889K | Buy |
5,288
+2,447
| +86% | +$264K | ﹤0.01% | 3395 |
|
|
2020
Q1 | $198K | Buy |
2,841
+232
| +9% | +$18.1K | ﹤0.01% | 3687 |
|
|
2019
Q4 | $168K | Buy |
2,609
+176
| +7% | +$10.2K | ﹤0.01% | 3833 |
|
|
2019
Q3 | $142K | Hold |
2,433
| – | – | ﹤0.01% | 3845 |
|
|
2019
Q2 | $144K | Hold |
2,433
| – | – | ﹤0.01% | 3890 |
|
|
2019
Q1 | $158K | Hold |
2,433
| – | – | ﹤0.01% | 3826 |
|
|
2018
Q4 | $130K | Hold |
2,433
| – | – | ﹤0.01% | 3870 |
|
|
2018
Q3 | $139K | Hold |
2,433
| – | – | ﹤0.01% | 3955 |
|
|
2018
Q2 | $142K | Buy |
2,433
+151
| +7% | +$8.88K | ﹤0.01% | 3940 |
|
|
2018
Q1 | $108K | Hold |
2,282
| – | – | ﹤0.01% | 3964 |
|
|
2017
Q4 | $134K | Hold |
2,282
| – | – | ﹤0.01% | 3919 |
|
|
2017
Q3 | $141K | Hold |
2,282
| – | – | ﹤0.01% | 3876 |
|
|
2017
Q2 | $142K | Hold |
2,282
| – | – | ﹤0.01% | 3892 |
|
|
2017
Q1 | $145K | Buy |
2,282
+693
| +44% | +$36.1K | ﹤0.01% | 3875 |
|
|
2016
Q4 | $61K | Buy |
1,589
+53
| +3% | +$1.84K | ﹤0.01% | 3982 |
|
|
2016
Q3 | $56K | Hold |
1,536
| – | – | ﹤0.01% | 3986 |
|
|
2016
Q2 | $56K | Hold |
1,536
| – | – | ﹤0.01% | 3995 |
|
|
2016
Q1 | $62K | Hold |
1,536
| – | – | ﹤0.01% | 3989 |
|
|
2015
Q4 | $66K | Hold |
1,536
| – | – | ﹤0.01% | 4011 |
|
|
2015
Q3 | $53K | Buy |
1,536
+322
| +27% | +$15.1K | ﹤0.01% | 4057 |
|
|
2015
Q2 | $66K | Sell |
1,214
-26
| -2% | -$1.55K | ﹤0.01% | 4018 |
|
|
2015
Q1 | $83K | Buy |
+1,240
| New | +$78.4K | ﹤0.01% | 4075 |
|
Other funds holding BCLI
LWM
HF
WCG
TSS
IC
Northern Trust's BCLI Position: Q4 2024 in Review
Northern Trust sold out of BRAINSTORM CELL THERAPUTC (BCLI) in Q4 2024, closing a stake of 7,491 shares — an estimated $25.9K sold.
Northern Trust first reported a position in BCLI in Q1 2015 and held it in 39 quarters. The position peaked at $5.37M in Q3 2020. 34 funds tracked by Wall St. Rank hold BCLI as of Q4 2024.
- Northern Trust reported no remaining BRAINSTORM CELL THERAPUTC position as of Q4 2024 after selling out during the quarter.
- Northern Trust sold 7,491 BRAINSTORM CELL THERAPUTC shares in Q4 2024, an estimated $25.9K.
- Northern Trust first reported a position in BRAINSTORM CELL THERAPUTC in Q1 2015 and held it in 39 quarters.
- Northern Trust's BRAINSTORM CELL THERAPUTC position peaked at $5.37M in Q3 2020.
- 34 funds tracked by Wall St. Rank held BRAINSTORM CELL THERAPUTC as of Q4 2024.
Based on Northern Trust's 13F filing for Q4 2024, filed 14 Feb 2025.